Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer
Rugo, Hope S., Pennella, Eduardo J., Gopalakrishnan, Unmesh, Hernandez-Bronchud, Miguel, Herson, Jay, Koch, Hans Friedrich, Loganathan, Subramanian, Deodhar, Sarika, Marwah, Ashwani, Manikhas, Alexey, Bondarenko, Igor, Mukhametshina, Guzel, Nemsadze, Gia, Parra, Joseph D., Abesamis-Tiambeng, Maria Luisa T., Baramidze, Kakhaber, Akewanlop, Charuwan, Vynnychenko, Ihor, Sriuranpong, Virote, Mamillapalli, Gopichand, Roy, Sirshendu, Yanez Ruiz, Eduardo Patricio, Barve, Abhijit, Fuentes-Alburo, Adolfo, Waller, Cornelius F.
Published in Breast cancer research and treatment (01.07.2021)
Published in Breast cancer research and treatment (01.07.2021)
Get full text
Journal Article
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
Rugo, Hope S., Pennella, Eduardo J., Gopalakrishnan, Unmesh, Hernandez-Bronchud, Miguel, Herson, Jay, Koch, Hans Friedrich, Loganathan, Subramanian, Deodhar, Sarika, Marwah, Ashwani, Manikhas, Alexey, Bondarenko, Igor, Parra, Joseph D., Abesamis-Tiambeng, Maria Luisa T., Akewanlop, Charuwan, Vynnychenko, Ihor, Sriuranpong, Virote, Roy, Sirshendu, Yanez Ruiz, Eduardo Patricio, Barve, Abhijit, Waller, Cornelius F.
Published in Breast (Edinburgh) (01.08.2021)
Published in Breast (Edinburgh) (01.08.2021)
Get full text
Journal Article
RE covery and SUR vival of patients with moderate to severe acute RE spiratory distress syndrome (ARDS) due to C OVID-19: a multicenter, single-arm, Phase IV itolizumab T rial: RESURRECT
Kr, Raveendra, Rathod, Chirag, Darnule, Rahul, Loganathan, Subramanian, Deodhar, Sarika, A, Radhika, Marwah, Ashwani, Chaudhari, Nitin M, Thakur, Binay K, Vaidyanathan, Sivakumar, Athalye, Sandeep Nilkanth
Published in Expert opinion on biological therapy (04.05.2023)
Published in Expert opinion on biological therapy (04.05.2023)
Get more information
Journal Article
Safety, Efficacy and pharmacokinetics of T1h, a humanized anti-CD6 monoclonal antibody, in moderate to severe chronic plaque psoriasis - Results from a randomized phase II trial. (96.13)
Anand, Arun, Assudani, Deepak, Nair, Pradip, Krishnamurthy, Sharmitha, Deodhar, Sarika, Arumugam, Muruganandam, Iyer, Harish, Melarkode, Ramakrishnan
Published in The Journal of immunology (1950) (01.04.2010)
Published in The Journal of immunology (1950) (01.04.2010)
Get full text
Journal Article